<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Tau protein levels in cerebrospinal fluid (CSF-tau) were determined in 29 patients with old cerebrovascular disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, 21 demented and eight non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e>), 69 patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) and 17 age-matched <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="1" pm="."><plain>The CSF-tau level in the vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD) group (24.0 +/- 17.0 pg/ml) was significantly lower (P &lt; 0.0001) than that in the AD group (90.0 +/- 45.3 pg/ml), but not significantly different from that in the non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> (18.1 +/- 10.2 pg/ml) or controls (20.3 +/- 13.0 pg/ml) </plain></SENT>
<SENT sid="2" pm="."><plain>Among the VD patients, 1/21 exceeded a cut-off value (mean +/- 2 SD of controls), whereas 8/69 of the AD patients had CSF-tau levels below this value </plain></SENT>
<SENT sid="3" pm="."><plain>These findings suggest that VD constitutes a group of <z:hpo ids='HP_0000726'>dementias</z:hpo> that can be separated from AD by <z:mpath ids='MPATH_458'>normal</z:mpath> CSF-tau levels </plain></SENT>
<SENT sid="4" pm="."><plain>CSF-tau determinations in combination with other clinical findings may provide another <z:chebi fb="6" ids="33295">diagnostic aid</z:chebi> in the differential diagnosis between VD and AD </plain></SENT>
</text></document>